News
Proposed Acquisitions Of 812 Capital LLC And Centre For Innovative Medical Technologies, LLC - Waiver From Compliance With Catalist Rules 1015(1)(a)(ii) And 1015(4)(a) In Respect Of The Requirement To Disclose The Pro Forma Financial Statements Of The Enlarged Group
BackJun 01, 2025
| Announcement Title | Waiver |
| Date & Time of Broadcast | Jun 1, 2025 18:30 |
| Status | New |
| Announcement Sub Title | Waiver from Catalist Rules 1015(1)(a)(ii) & 1015(4)(a) in respect of Pro Forma Financial Statements |
| Announcement Reference | SG250601OTHRD1HF |
| Submitted By (Co./ Ind. Name) | Marat Devlet-Kildeyev |
| Designation | Chief Executive Officer and Executive Director |
| Description (Please provide a detailed description of the event in the box below) | Please see attached. This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Mr Shervyn Essex, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, sponsorship@ppcf.com.sg. |
Attachments
- Attachment 1 (Size: 233,397 bytes)
